You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (40) |
Back to Search
Anti-tumor activity of betulinic acid and its apoptotic on kb cell lines
- In: SIG Bioavailability / Bioequivalence - Poster Session
- At: Salvadore (Brazil) (2006)
- Type: Poster
- Poster code: BB-P-003
- By: MA, Li (Beijing Institute of Biomedicine, China)
- Co-author(s): Wu, Hongyu (Beijing Institute of Biomedicine, China)
Ni, Mingyu (Beijing Institute of Biomedicine, China)
Wang, Jiaping (Beijing Institute of Biomedicine, China) - Abstract:
This paper focused on the study of the in vitro anticancer activity of Betulinic Acid (BetA) and growth inhibition of S180 in vivo.
BetA 800,1 200 mg•kg-1 i.g. markedly inhibited the growth of S180 cell in vivo. By the way of our lab, MTT assay showed that BetA could inhibit the proliferation, in a dosage dependent manner, of the cells of.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026